DOUBLE BOND PHARMACEUTICAL INTERNATIONAL AB CLASS BDOUBLE BOND PHARMACEUTICAL INTERNATIONAL AB CLASS BDOUBLE BOND PHARMACEUTICAL INTERNATIONAL AB CLASS B

DOUBLE BOND PHARMACEUTICAL INTERNATIONAL AB CLASS B

No trades
See on Supercharts
Market capitalization
‪24.38 M‬SEK
−0.0690SEK
‪−7.11 M‬SEK
‪1.09 M‬SEK
Beta (1Y)
0.32

About DOUBLE BOND PHARMACEUTICAL INTERNATIONAL AB CLASS B


CEO
Igor Lokot
Headquarters
Uppsala
Founded
2014
ISIN
SE0007185525
FIGI
BBG009DFBCW8
Double Bond Pharmaceutical International AB is a pharmaceutical company, which engages in developing and commercializing approaches for treatment of cancers, infections, autoimmune diseases, and life-threatening disorders. It also involves in designing medicinal products for patients suffering from diseases such as cancer, inflammation, asthma or diabetes. The company was founded on November 21, 2014 and is headquartered in Uppsala, Sweden.

Check out other big names from the same industry as DBP.B.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of DBP.B is 0.1220 SEK — it has increased by 2.95% in the past 24 hours. Watch DOUBLE BOND PHARMACEUTICAL INTERNATIONAL AB CLASS B stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NGM exchange DOUBLE BOND PHARMACEUTICAL INTERNATIONAL AB CLASS B stocks are traded under the ticker DBP.B.
DBP.B stock has fallen by −4.69% compared to the previous week, the month change is a −16.44% fall, over the last year DOUBLE BOND PHARMACEUTICAL INTERNATIONAL AB CLASS B has showed a −67.89% decrease.
We've gathered analysts' opinions on DOUBLE BOND PHARMACEUTICAL INTERNATIONAL AB CLASS B future price: according to them, DBP.B price has a max estimate of 0.32 SEK and a min estimate of 0.32 SEK. Watch DBP.B chart and read a more detailed DOUBLE BOND PHARMACEUTICAL INTERNATIONAL AB CLASS B stock forecast: see what analysts think of DOUBLE BOND PHARMACEUTICAL INTERNATIONAL AB CLASS B and suggest that you do with its stocks.
DBP.B reached its all-time high on Nov 6, 2018 with the price of 19.4000 SEK, and its all-time low was 0.1000 SEK and was reached on Jun 13, 2025. View more price dynamics on DBP.B chart.
See other stocks reaching their highest and lowest prices.
DBP.B stock is 11.76% volatile and has beta coefficient of 0.32. Track DOUBLE BOND PHARMACEUTICAL INTERNATIONAL AB CLASS B stock price on the chart and check out the list of the most volatile stocks — is DOUBLE BOND PHARMACEUTICAL INTERNATIONAL AB CLASS B there?
Today DOUBLE BOND PHARMACEUTICAL INTERNATIONAL AB CLASS B has the market capitalization of ‪24.38 M‬, it has decreased by −4.38% over the last week.
Yes, you can track DOUBLE BOND PHARMACEUTICAL INTERNATIONAL AB CLASS B financials in yearly and quarterly reports right on TradingView.
DBP.B net income for the last quarter is ‪−441.85 K‬ SEK, while the quarter before that showed ‪−1.10 M‬ SEK of net income which accounts for 59.92% change. Track more DOUBLE BOND PHARMACEUTICAL INTERNATIONAL AB CLASS B financial stats to get the full picture.
No, DBP.B doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. DOUBLE BOND PHARMACEUTICAL INTERNATIONAL AB CLASS B EBITDA is ‪−5.75 M‬ SEK, and current EBITDA margin is −132.78%. See more stats in DOUBLE BOND PHARMACEUTICAL INTERNATIONAL AB CLASS B financial statements.
Like other stocks, DBP.B shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade DOUBLE BOND PHARMACEUTICAL INTERNATIONAL AB CLASS B stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So DOUBLE BOND PHARMACEUTICAL INTERNATIONAL AB CLASS B technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating DOUBLE BOND PHARMACEUTICAL INTERNATIONAL AB CLASS B stock shows the sell signal. See more of DOUBLE BOND PHARMACEUTICAL INTERNATIONAL AB CLASS B technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.